Geron

Yahoo Finance • last month

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024

FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights b... Full story

Yahoo Finance • last month

Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential?

We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the... Full story

Yahoo Finance • 2 months ago

Is Geron Corporation (GERN) the Best NASDAQ Stock Under $5?

We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best NASDAQ stocks under $5. Job Market Cools Yet Economists Remain Optimistic About Stab... Full story

Yahoo Finance • 6 months ago

Is Geron Stock a Buy Following Its First New Drug Approval?

Shares of Geron(NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was reacting to news the company's investors had been waiting to hear for decades. On June 6, the U.S. Food and Drug Administration (FDA) approved G... Full story

Yahoo Finance • 8 months ago

Geron Stock Is Soaring After Hours: What's Going On?

Geron Corp (NASDAQ:GERN) shares are soaring in Thursday's after-hours session after the company announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted in favor of the clinical benefit/r... Full story

Yahoo Finance • 12 months ago

Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS FOSTER CITY, Calif., December 04, 2023--(BUSINESS WIRE)--Geron Corporation (Nasdaq:... Full story

Yahoo Finance • last year

Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript

Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript November 2, 2023 Geron Corporation beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.1. Operator: Good morning. My name is Audrey, and I will be yo... Full story

Yahoo Finance • last year

What's Going On With Geron Stock Today

Geron Corporation (NASDAQ: GERN) submitted a marketing application with the FDA seeking approval for imetelstat for the treatment of transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes... Full story

Yahoo Finance • 2 years ago

Q1 2023 Geron Corp Earnings Call

Participants Anil Kapur; Executive VP of Corporate Strategy & Chief Commercial Officer; Geron Corporation Aron Feingold; VP of IR & Corporate Communications; Geron Corporation Faye Feller; Executive VP & Chief Medical Officer; Geron Cor... Full story

Yahoo Finance • 2 years ago

10 Hot Healthcare Stocks To Buy Now

In this article, we discuss the 10 hot healthcare stocks to buy now. If you want to read about some more hot healthcare stocks to buy now, go directly to 5 Hot Healthcare Stocks To Buy Now. The rise of consumer prices has often lagged beh... Full story

Yahoo Finance • 2 years ago

Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.

Leadership in place for core commercial functions, including in Market Access, Trade & Channel Relations, Commercial Operations, Analytics, Marketing, Sales and Medical Affairs Company continues stage-gated commercial readiness efforts for... Full story

Yahoo Finance • 2 years ago

Small Caps Begin to Rebound: 10 Stocks to Buy Now

In this article, we discuss 10 rebounding small cap stocks to buy now. If you want to see the top stocks in this category, check out 5 Rebounding Small-Cap Stocks to Buy Now. Carter Worth, the CEO of Worth Charting, joined CNBC’s ‘The Exc... Full story

Yahoo Finance • 3 years ago

Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants

FOSTER CITY, Calif., April 01, 2022--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 53,333,334 sha... Full story